Prostate Cancer
Combining drugs for better prostate cancer treatment?
AFT-19 trial: Investigating androgen blockade intensification in prostate cancer.
New prostate cancer inhibitor holds massive promise
Cell-active inhibitor designed for methyltransferase KMT9.
UCLA unravels aggressive growth in prostate cancers, eluding treatment
Temporal evolution reveals dual lineages in prostate cancer transformation.
Cost-effective prostate cancer focal therapy benefits
Study analyzes the cost-effectiveness of focal therapy, radical prostatectomy, and radiotherapy for prostate cancer.
Advancements in aggressive prostate cancer therapy
Enzalutamide improves recurrent prostate cancer prognosis.
Turning routine vaccines into weapons against cancer
Using Salmonella to fight pancreatic cancer: How CD8 T cells can help.
11 genes linked to aggressive prostate cancer mutations
Using germline sequencing to guide prostate cancer gene panel testing.
Early breakfast linked to lower risk of type 2 Diabetes
Eating early and often may reduce your risk of Type 2 Diabetes.
A novel approach to target enhancer-addicted cancers
Potential treatment approach for over 90% of prostate cancers.
Men with large waistline are more likely to die of prostate cancer
There is a link between central adiposity and risk of death from prostate cancer.
Being active reduces the risk of prostate cancer
Prostate cancer is the most common cancer in men in the UK*, yet we still don't know all of its causes.
Scientists used computer model to predict prostate cancer progression
Other than skin cancer, prostate cancer is the most common cancer in men in the western world. About 1 man in 9 will be diagnosed...